TBPH

TBPH

USD

Theravance Biopharma Inc. Ordinary Shares

$14.750-0.110 (-0.740%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$14.860

Máximo

$15.001

Mínimo

$14.420

Volumen

0.49M

Fundamentos de la Empresa

Capitalización de Mercado

742.8M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.42M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $7.9Actual $14.750Máximo $15.335

Noticias Relacionadas

PR Newswire

Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System

Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will be participating at the 36th International Symposium on the Autonomic Nervous...

Ver más
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
PR Newswire

Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2025 financial results and provide a business update after market close on...

Ver más
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), today announced that it will be presenting two rapid-fire...

Ver más
Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.